You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 7, July 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hidradenitis Suppurativa

Glucose Tolerance, Clinical, Microbiologic, and Immunologic Features and HLA Frequencies in 27 Patients

Sean O'Loughlin, MB, FRCPI; Robert Woods, MPhil, CBiol, MIBiol, FIMLS; Peadar N. Kirke, FFCMI, FFCM, MSc, DCH, DObst; Fergus Shanahan, MRCP; Anne Byrne, FIMLS; Michael Ivor Drury, MD, DSc, FRCPI, FRCOG

Arch Dermatol. 1988;124(7):1043-1046.


Abstract

• Glucose tolerance, lymphocyte populations, and HLA types were studied in 27 patients with untreated hidradenitis suppurativa; 18 of these patients had a negative history for acne vulgaris. Six patients (22%) had an increased incidence of impaired glucose tolerance. We failed to confirm a previous report of high incidence of flat glucose tolerance curves. The frequency of HLA-A and HLA-B antigen loci and the median values of peripheral blood T lymphocytes were similar to the control population. However, seven patients with moderate or severe clinical disease had a marked reduction in T lymphocytes and these patients had an increased frequency of the HLA antigens, A1 and B8. These results suggest that T lymphocytes may play a role in the pathogenesis of hidradenitis suppurativa and that HLA-A1 and HLA-B8 may predispose the patient to more severe disease, but further research is necessary to clarify this.

(Arch Dermatol 1988;124:1043-1046)



Author Affiliations

From the Departments of Dermatology (Dr O'Loughlin), Immunology (Mr Woods and Ms Byrne), and Endocrinology (Drs Shanahan and Drury), Mater Misericordiae Hospital, and the Medico-Social Research Board (Dr Kirke), Dublin.


Footnotes

Accepted for publication Oct 20, 1987.

Reprint requests to Mater Misericordiae Hospital, Eccles Street, Dublin 7, Ireland (Dr O'Loughlin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.